Clinical Trials Directory

Trials / Completed

CompletedNCT02327091

The Effect of Alfacalcidol on Muscle Strength in Elderly Indonesian Women : A Randomized Controlled Trial

Phase 3 Study of Vitamin D Analog (Alfacalcidol) on Muscle Strength in Elderly Indonesian Women Who Have Low Handgrip Strength

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
122 (actual)
Sponsor
Indonesia University · Academic / Other
Sex
Female
Age
60 Years
Healthy volunteers
Accepted

Summary

The age-related increase in falls is strongly associated with a decline in muscle strength by the mechanism of sarcopenia. There has been great interest in developing approaches to counteract the effects of sarcopenia, and thereby reduce the age-related decline in muscle mass with vitamin D that have muscular effect. However, a limited number of studies demonstrate a vitamin D analog (alfacalcidol) increase in lower body muscle strength in adults with vitamin D deficiency. A double-blinded randomized controlled trial was conducted in order to determine the effect of alfacalcidol on the upper-body muscle strength in Indonesian elderly women in age group of 60 or more who had low handgrip strength.

Detailed description

A total 122 elderly women were enrolled to this study. It was determined subjects with handgrip strength less than 22 kg and measured using handheld dynamometer. There were 95 subjects fulfilled the eligible criteria. These subjects were randomized into two groups, one group of 47 subjects received alfacalcidol 0.5 mcg/day and the other group received placebo. Each subject was given calcium 500 mg/day. After 12 weeks of intervention, 88 subjects had the second muscle strength measurement (7 dropped out).

Conditions

Interventions

TypeNameDescription
DRUGalfacalcidolOne group of 47 subjects received alfacalcidol 0.5 mcg/day and the other group received placebo

Timeline

Start date
2012-04-01
Primary completion
2012-09-01
Completion
2012-12-01
First posted
2014-12-30
Last updated
2014-12-30

Locations

1 site across 1 country: Indonesia

Source: ClinicalTrials.gov record NCT02327091. Inclusion in this directory is not an endorsement.